Stereotactic body radiotherapy as a boost after external beam radiotherapy for high-risk prostate cancer patients
Conclusions: SBRT boost treatment after pelvic irradiation has been used with a good biochemical control and acceptable toxicity in high-risk prostate cancer patients. More extensive randomized trial results are needed on the subject.
Source: Indian Journal of Cancer - Category: Cancer & Oncology Authors: Menekse Turna Halil Akboru Ekin Ermis Sedenay Oskeroglu Selvi Dincer Suleyman Altin Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | External Beam Therapy | Gastroenterology | India Health | Men | Prostate Cancer | Radiation Therapy | Study | Toxicology